Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens. (2021)

First Author: Hussain H
Attributed to:  Production of difficult to express essential bacterial proteins funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00253-021-11405-9

PubMed Identifier: 34180005

Publication URI: http://europepmc.org/abstract/MED/34180005

Type: Journal Article/Review

Volume: 105

Parent Publication: Applied microbiology and biotechnology

Issue: 13

ISSN: 0175-7598